Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × dostarlimab × Clear all

NCT05060432 2024-06-21

TIG-006

Phase 1/2 Active not recruiting

DermatologicHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Melanoma